MYGN - Myriad Genetics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
No. of Analysts1381410
Avg. Estimate0.330.311.211.4
Low Estimate0.310.31.191.33
High Estimate0.350.331.221.5
Year Ago EPS0.30.261.051.21
Revenue EstimateCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
No. of Analysts117149
Avg. Estimate195.76M191.64M771.06M781.46M
Low Estimate194M181.2M741.3M745M
High Estimate200M199.23M777.7M826M
Year Ago Sales200.5M190.2M771.4M771.06M
Sales Growth (year/est)-2.40%0.80%-0.00%1.30%
Earnings History6/29/20179/29/201712/30/20173/30/2018
EPS Est.0.260.210.240.27
EPS Actual0.30.260.310.31
Difference0.040.050.070.04
Surprise %15.40%23.80%29.20%14.80%
EPS TrendCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
Current Estimate0.330.311.211.4
7 Days Ago0.330.311.211.4
30 Days Ago0.330.311.211.42
60 Days Ago0.330.311.21.43
90 Days Ago0.330.311.21.41
EPS RevisionsCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/A1N/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days11N/A1
Growth EstimatesMYGNIndustrySectorS&P 500
Current Qtr.10.00%N/AN/A0.47
Next Qtr.19.20%N/AN/A0.46
Current Year15.20%N/AN/A0.22
Next Year15.70%N/AN/A0.10
Next 5 Years (per annum)16.85%N/AN/A0.11
Past 5 Years (per annum)-14.39%N/AN/AN/A